$DRIO
DarioHealth Corp. Stock $drio

$drio Overview Financials Valuation SEC Filings Company Website

2014 Q2 Form 10-Q Financial Statement

#000114420414050135 Filed on August 14, 2014

Income Statement

Concept	2014 Q2	2013 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue	$605.0K	$0.00
YoY Change
Gross Profit	-$605.0K	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.670M	$1.560M
YoY Change	7.05%	271.43%
% of Gross Profit
Research & Development	$1.333M	$1.416M
YoY Change	-5.86%	215.26%
% of Gross Profit
Depreciation & Amortization	$160.0K	$190.0K
YoY Change	-15.79%
% of Gross Profit
Operating Expenses	$2.998M	$3.596M
YoY Change	-16.63%	700.63%
Operating Profit	-$3.603M	-$3.596M
YoY Change	0.19%	315.08%
Interest Expense	$390.0K	-$1.680M
YoY Change	-123.21%
% of Operating Profit
Other Income/Expense, Net	$349.0K	-$1.690M
YoY Change	-120.65%	191727.47%
Pretax Income	-$3.250M	-$5.290M
YoY Change	-38.56%	508.05%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.254M	-$5.286M
YoY Change	-38.44%	509.53%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.14	-$0.29
Diluted Earnings Per Share	-$0.15	-$0.29
COMMON SHARES
Basic Shares Outstanding	22.99M shares	18.33M shares
Diluted Shares Outstanding	23.20M shares	18.33M shares

Balance Sheet

Concept	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.000M	$7.200M
YoY Change	-72.22%
Cash & Equivalents	$1.819M	$7.026M
Short-Term Investments	$200.0K	$100.0K
Other Short-Term Assets	$0.00	$0.00
YoY Change
Inventory	$22.00K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$2.362M	$7.807M
YoY Change	-69.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$991.0K	$1.486M
YoY Change	-33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$100.0K
YoY Change	-100.0%
Total Long-Term Assets	$1.040M	$1.594M
YoY Change	-34.76%
TOTAL ASSETS
Total Short-Term Assets	$2.362M	$7.807M
Total Long-Term Assets	$1.040M	$1.594M
Total Assets	$3.402M	$9.401M
YoY Change	-63.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$700.0K	$700.0K
YoY Change	0.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.776M	$1.327M
YoY Change	33.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$5.400M	$6.200M
YoY Change	-12.9%
Total Long-Term Liabilities	$5.400M	$6.200M
YoY Change	-12.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.776M	$1.327M
Total Long-Term Liabilities	$5.400M	$6.200M
Total Liabilities	$7.200M	$7.600M
YoY Change	-5.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.24M
YoY Change
Common Stock	$2.000K	$1.996K
YoY Change	0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.800M	$1.842M
YoY Change
Total Liabilities & Shareholders Equity	$3.400M	$9.401M
YoY Change	-63.84%

Cashflow Statement

Concept	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	-$3.254M	-$5.286M
YoY Change	-38.44%	509.53%
Depreciation, Depletion And Amortization	$160.0K	$190.0K
YoY Change	-15.79%
Cash From Operating Activities	-$2.080M	-$2.050M
YoY Change	1.46%	327.08%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	-$690.0K
YoY Change	-95.65%	6800.0%
Acquisitions
YoY Change
Other Investing Activities	$20.00K	-$180.0K
YoY Change	-111.11%
Cash From Investing Activities	-$10.00K	-$870.0K
YoY Change	-98.85%	8600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	100.0K	9.650M
YoY Change	-98.96%
NET CHANGE
Cash From Operating Activities	-2.080M	-2.050M
Cash From Investing Activities	-10.00K	-870.0K
Cash From Financing Activities	100.0K	9.650M
Net Change In Cash	-1.990M	6.730M
YoY Change	-129.57%	-1473.47%
FREE CASH FLOW
Cash From Operating Activities	-$2.080M	-$2.050M
Capital Expenditures	-$30.00K	-$690.0K
Free Cash Flow	-$2.050M	-$1.360M
YoY Change	50.74%	189.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-TRANSFORM: none; TEXT-INDENT: -56.7pt; MARGIN: 0pt 0px 0pt 56.7pt; FONT: bold 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" align="justify">NOTE 3:-       UNAUDITED INTERIM FINANCIAL STATEMENTS</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-TRANSFORM: none; TEXT-INDENT: -28.35pt; MARGIN: 0pt 0px 0pt 85.05pt; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-TRANSFORM: none; TEXT-INDENT: 0in; MARGIN: 0pt 0px 0pt 55.7pt; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px" align="justify">The accompanying unaudited interim consolidated financial statements as of June 30, 2014, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company’s consolidated financial position as of June 30, 2014, the Company’s consolidated results of operations and the Company’s consolidated cash flows for the six and three months ended June 30, 2014. Results for the six and three months periods ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ended December 31, 2014.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23013889	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6271000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4418000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1819000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2263000	USD
CY2014Q2	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	0	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	38000	USD
CY2014Q2	us-gaap	Short Term Investments ShortTermInvestments	166000	USD
CY2013Q4	us-gaap	Short Term Investments ShortTermInvestments	154000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	2362000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2930000	USD
CY2014Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	49000	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	41000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	991000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1145000	USD
CY2014Q2	us-gaap	Assets Assets	3402000	USD
CY2013Q4	us-gaap	Assets Assets	4116000	USD
CY2014Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	681000	USD
CY2013Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	586000	USD
CY2014Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1095000	USD
CY2013Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	920000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1776000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1506000	USD
CY2014Q2	drio	Liability Related To Warrants LiabilityRelatedToWarrants	5379000	USD
CY2013Q4	drio	Liability Related To Warrants LiabilityRelatedToWarrants	2696000	USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	2000	USD
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22486000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19915000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4116000	USD
CY2014Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	923	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P6M22D
	drio	Percentage Of Aggregate Of Weighted Average Prices Of Common Stock PercentageOfAggregateOfWeightedAveragePricesOfCommonStock	0.9	pure
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	534000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	560000	USD
CY2013Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	276000	USD
CY2014Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	263000	USD
	drio	Legal And Professional Fees LegalAndProfessionalFees	469000	USD
	drio	Legal And Professional Fees LegalAndProfessionalFees	453000	USD
CY2013Q2	drio	Legal And Professional Fees LegalAndProfessionalFees	336000	USD
CY2014Q2	drio	Legal And Professional Fees LegalAndProfessionalFees	242000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1358000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	877000	USD
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	280000	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	531000	USD
	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	1011000	USD
	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	0	USD
CY2013Q2	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	618000	USD
CY2014Q2	drio	Stock And Warrants Issued During Period To Service Provider StockAndWarrantsIssuedDuringPeriodToServiceProvider	0	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3420000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2146000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1516000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1292000	USD
	drio	Bank Charges BankCharges	14000	USD
	drio	Bank Charges BankCharges	7000	USD
CY2013Q2	drio	Bank Charges BankCharges	10000	USD
CY2014Q2	drio	Bank Charges BankCharges	2000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-27000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-9000	USD
CY2013Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-16000	USD
CY2014Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	489000	USD
CY2013Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
CY2014Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	41000	USD
	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-3800000	USD
	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	538000	USD
CY2013Q2	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	-1664000	USD
CY2014Q2	drio	Revaluation Of Warrant Income Expenses RevaluationOfWarrantIncomeExpenses	396000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3841000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	33000	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1690000	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	349000	USD
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16590423	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22152675	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16590423	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20071816	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18327387	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22985523	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23013889	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20071816	shares
CY2014Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2091000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2440000	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1416000	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1333000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1161000	USD
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	659000	USD
CY2013Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	664000	USD
CY2014Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	373000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6672000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3596000	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3603000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-41000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-505000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26000	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10513000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-6238000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-5286000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-3254000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22260952	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18327387	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23202077	shares
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-1070000	USD
CY2013	drio	Stock Issued During Period Value New Issues February And June2013 StockIssuedDuringPeriodValueNewIssuesFebruaryAndJune2013	996000	USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	488000	USD
CY2013	drio	Warrant Issued During Period For Services Value March And May2013 WarrantIssuedDuringPeriodForServicesValueMarchAndMay2013	523000	USD
	drio	Stock Issued During Period Value New Issues February2014 StockIssuedDuringPeriodValueNewIssuesFebruary2014	1013000	USD
CY2013	drio	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	708000	USD
	drio	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	352000	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	USD
	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	2862000	USD
	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	1199000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3213000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1199000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-13931000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	489000	USD
	us-gaap	Depreciation Depreciation	314000	USD
	us-gaap	Depreciation Depreciation	358000	USD
	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	208000	USD
	drio	Increase Decrease In Accounts Receivables And Prepaid Expense IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense	-120000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	371000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	39000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	350000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	175000	USD
	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	-3800000	USD
	drio	Increase Decrease In Fair Value Of Warrants IncreaseDecreaseInFairValueOfWarrants	538000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3021000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	105000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	130000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	14000	USD
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	158000	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	92000	USD
	us-gaap	Payments To Acquire Leases Held For Investment PaymentsToAcquireLeasesHeldForInvestment	8000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1146000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	150000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1329000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-130000	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	9951000	USD
	drio	Proceeds From Issuance Of Common Stock And Warrants ProceedsFromIssuanceOfCommonStockAndWarrants	3754000	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	195000	USD
	drio	Proceeds From Stock Options And Warrants Exercised ProceedsFromStockOptionsAndWarrantsExercised	350000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10146000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4104000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5796000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-444000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1230000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7026000	USD
	drio	Receivable On Account Of Shares ReceivableOnAccountOfShares	31000	USD
	drio	Receivable On Account Of Shares ReceivableOnAccountOfShares	0	USD
	drio	Conversionofwarantliabilitytocommonstock Conversionofwarantliabilitytocommonstock	385000	USD
	drio	Conversionofwarantliabilitytocommonstock Conversionofwarantliabilitytocommonstock	9000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	39000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	56000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	LabStyle Innovations Corp.
	dei	Entity Central Index Key EntityCentralIndexKey	0001533998
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	DRIO
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25498305	shares
CY2014Q2	drio	Other Accounts Receivable And Prepaid Expenses OtherAccountsReceivableAndPrepaidExpenses	355000	USD
CY2013Q4	drio	Other Accounts Receivable And Prepaid Expenses OtherAccountsReceivableAndPrepaidExpenses	475000	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	22000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26241000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20003000	USD
	us-gaap	Revenues Revenues	0	USD
	us-gaap	Revenues Revenues	0	USD
CY2013Q2	us-gaap	Revenues Revenues	0	USD
CY2014Q2	us-gaap	Revenues Revenues	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1026000	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2014Q2	us-gaap	Cost Of Revenue CostOfRevenue	605000	USD
	us-gaap	Gross Profit GrossProfit	0	USD
	us-gaap	Gross Profit GrossProfit	-1026000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	0	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	-605000	USD
	us-gaap	Operating Expenses OperatingExpenses	6672000	USD
	us-gaap	Operating Expenses OperatingExpenses	5245000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	3596000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	2998000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	22000	USD
	us-gaap	Other Expenses OtherExpenses	48000	USD
	us-gaap	Other Expenses OtherExpenses	256000	USD
CY2013Q2	us-gaap	Other Expenses OtherExpenses	6000	USD
CY2014Q2	us-gaap	Other Expenses OtherExpenses	256000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2014Q1	drio	Stockbased Compensation Warrants And Restricted Shares StockbasedCompensationWarrantsAndRestrictedShares	690000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	343000	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-303000	USD
CY2013Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	0	USD
CY2014Q2	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-290000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-10513000	USD
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-6541000	USD
CY2013Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-5286000	USD
CY2014Q2	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3544000	USD
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	108277	shares
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	216554	shares

Files In Submission

Name	View Source	Status
0001144204-14-050135-index-headers.html	Edgar Link	pending
0001144204-14-050135-index.html	Edgar Link	pending
0001144204-14-050135.txt	Edgar Link	pending
0001144204-14-050135-xbrl.zip	Edgar Link	pending
drio-20140630.xml	Edgar Link	completed
drio-20140630.xsd	Edgar Link	pending
drio-20140630_cal.xml	Edgar Link	unprocessable
drio-20140630_def.xml	Edgar Link	unprocessable
drio-20140630_lab.xml	Edgar Link	unprocessable
drio-20140630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v385596_10q.htm	Edgar Link	pending
v385596_ex31-1.htm	Edgar Link	pending
v385596_ex31-2.htm	Edgar Link	pending
v385596_ex32-1.htm	Edgar Link	pending
v385596_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DRIO
DarioHealth Corp. Stock $drio

2014 Q2 Form 10-Q Financial Statement

#000114420414050135 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO DarioHealth Corp. Stock $drio

2014 Q2 Form 10-Q Financial Statement

#000114420414050135 Filed on August 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DRIO
DarioHealth Corp. Stock $drio